Interested parties have until March 21 to comment on an interim policy statement on dispensing controlled substances for pain. A Federal Register statement outlines several inaccuracies that were included in an August 2004 “frequently asked questions” document that appeared on the Drug Enforcement Administration Web site. The statement also notes that the DEA plans to publish a document “aimed at providing guidance and reassurance to physicians who engage in legitimate pain treatment while deterring the unlawful conduct of a small number of physicians” Information on submitting comments can be found in a Federal Register notice published on Jan. 18; that notice is online at www.access.gpo.gov/su_docs/fedreg/a050118c.html